Accelerating clinical research has become a strategic objective for both industry and academic sponsors. Budget constraints, global competition, and increasing patient expectations all converge toward a growing demand for efficiency in clinical research.
Yet at the heart of this transformation, one actor remains underestimated: investigational sites.
In practice, investigational sites and their clinical teams directly determine the real feasibility of clinical research, the quality of the data collected, and the ability to meet expected timelines. Without efficient investigational sites, even the most innovative clinical development strategies struggle to deliver results.
Clinical Research Timelines Are Decided at Investigational Sites
Regulatory developments such as the European Regulation (EU) 536/2014 on clinical trials have simplified and harmonized procedures across Europe. However, the operational reality of clinical research remains strongly dependent on the performance of investigational sites.
The European Medicines Agency reminds that the protection of participants and the generation of reliable data must prevail over all other considerations.
Achieving this objective in clinical research depends directly on the capabilities of investigational sites, including:
- Availability of qualified investigators
- Human resources within investigational sites
- Capacity to recruit eligible patients
- Mastery of administrative and contractual procedures
In other words, regulatory acceleration in clinical research does not automatically translate into operational acceleration if investigational sites lack sufficient resources.
Investigators: Balancing Scientific Excellence and Administrative Burden
In clinical research, the role of the principal investigator goes far beyond patient recruitment. Investigators at investigational sites are responsible for:
- Compliance with the study protocol
- Participant safety throughout the study
- Data completeness and quality
- Compliance with Good Clinical Practice standards (ICH E6)
However, in modern clinical research, protocols have become increasingly complex. As a result, the administrative and documentation workload at investigational sites has grown significantly.
The modernization of Good Clinical Practice guidelines — ICH E6(R3) — emphasizes the importance of a risk-based approach and the integration of Quality by Design principles in clinical research.
https://www.ich.org/page/efficacy-guidelines
This evolution implicitly recognizes an operational reality: investigational sites cannot indefinitely absorb increasing complexity in clinical research without impacting timelines and performance.
Patient Recruitment in Clinical Research: A Local Challenge
Patient recruitment is frequently cited as one of the main causes of delays in clinical research.
https://www.datacapt.com/blog/patient-recruitment-in-clinical-trials
For example, among more than 10,000 oncology trials worldwide, around 60% recruit fewer than five participants per investigational site, and more than 20% recruit none at all.
source: https://servier.com
However, recruitment challenges in clinical research are not solely related to population size or marketing strategy.
Recruitment success at investigational sites depends on several local factors:
- Alignment between inclusion criteria and real clinical practice
- Local healthcare pathways
- Motivation and experience of clinical teams
- Patient understanding of the protocol
A protocol that appears statistically optimized for clinical research may prove unrealistic at investigational sites if real-world clinical constraints have not been sufficiently anticipated.
Digital Tools in Clinical Research: Support for Investigational Sites, Not a Magic Solution
Digital tools are increasingly used to support investigational sites in clinical research. Remote monitoring platforms, electronic data capture systems, and decentralized trial technologies can improve efficiency.
However, without:
- Adequate training for investigational sites
- Dedicated staff and support
- Simplified operational processes
digitalization in clinical research may become an additional burden rather than a true facilitator.
The challenge is therefore not purely technological, but also organizational. Successful clinical research requires digital tools that are truly adapted to the operational realities of investigational sites.
Investigational Sites as a Strategic Driver of Clinical Research Attractiveness
In an increasingly competitive global environment, the attractiveness of a country for clinical research largely depends on the performance of its investigational sites.
An investigational site capable of:
- Opening trials rapidly
- Recruiting patients efficiently
- Producing high-quality data
quickly becomes a strategic partner for sponsors conducting clinical research.
Conversely, investigational sites that are under-resourced or overloaded can significantly slow down clinical development programs.
Accelerating Clinical Research Requires Collaboration with Investigational Sites
Accelerating clinical research is not simply about shortening regulatory evaluation timelines or multiplying digital tools.
It requires:
- Realistic feasibility assessments at investigational sites
- Early involvement of investigators in clinical research design
- Methodological simplification whenever possible
- Anticipation of operational constraints faced by investigational sites
- Meaningful patient engagement
Investigational sites are not merely a logistical step in clinical research. They are the operational backbone of clinical development.
Ultimately, accelerating clinical research means strengthening the capacity, stability, and recognition of teams working within investigational sites.
Because without them, no innovation — however promising — can ultimately reach patients.
